“Phase II Trial of Humanized Anti-Lewis Y Monoclonal Antibody for Advanced Hormone Receptor-Positive Breast Cancer That Progressed Following Endocrine Therapy”. Clinics, vol. 76, Oct. 2021, p. e3146, https://doi.org/10.6061/clinics/2021/e3146.